Dr. Pritha Mukherjee graduated from the University of Calcutta with a B.S. in 2011. In 2013, she joined Prof. K. Panda’s lab (University of Calcutta) as a research intern and worked on arsenic-induced cellular and molecular damage, which introduced her to animal and cell culture models, molecular biology, and proteomic analyses of oxidative damage in organs. She joined Dr. A.N. Chaudhuri (Lady Brabourne College Calcutta) in 2014 to work on silver nano-particles modified with gangliosides, and she tested their effect upon pathogenic microbes. Her doctoral thesis work in the lab of Prof. U. Chatterji (University of Calcutta) started in 2015 with an exploration of the molecular mechanisms of cancer relapse, with a focus on cancer stem cells in breast cancer using both clinical samples and cell lines. Her skills were further advanced in 2019 in the laboratory of Prof. M. Germain (Medical Biology, UQTR, Canada), where she studied mitochondrial dynamics in cancer. Her research interests include cancer biology, cancer biomarkers, cell signaling, and Western blot analysis. Currently, she is a Post-Doctoral Fellow at the Clinical and Translational Glycoscience Research Center, Lombardi Comprehensive Cancer Center, Georgetown University.
Dr. Xin Zhou graduated with a B.S. from the University of Science and Technology of China in 1997. He obtained his Ph.D. from Texas A&M University in 2005. He first joined Dr. Radoslav Goldman’s lab at the Department of Oncology and Clinical and Translational Glycoscience Research Center, Georgetown University, in 2012 as a postdoc researcher. He came back as a Research Specialist in 2020. His current research focuses on characterizing protein functions in cell lines and mouse models.
Bruce Davidson, MD, FACS, has been a faculty member of the Georgetown Department of Otolaryngology—Head and Neck Surgery since 1994 and has been professor and chairman of the department since 2002. Dr. Davidson is a graduate of the Georgetown Otolaryngology—Head and Neck Surgery residency program and, after completing a fellowship in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center, he returned to Washington to join the faculty. His special interests include head and neck cancer, parathyroid surgery, robotic-assisted surgery, salivary gland disease, and thyroid cancer. Dr. Davidson is an active member of Georgetown’s weekly multidisciplinary head and neck tumor conference.
Dr. Julius Benicky completed his PhD in Physiology at the Slovak Academy of Sciences, studying hormonal, metabolic, and osmotic regulation in the control of the endocrine pancreas and insulin secretion on a model of isolated islets of Langerhans and β cells. He gained experience in neurobiology and neuroanatomy during his post-doctoral training under the supervision of Dr. Juan Saavedra at the National Institute of Mental Health in Bethesda, MD, studying the relationship between the activity of the brain renin-angiotensin system and pathophysiological processes in the central nervous system, including neuroinflammatory response, oxidative stress, and neurotoxicity. He currently holds a Research Instructor position in the Goldman’s Lab at the Department of Oncology at Georgetown University, where he has expanded his previous experience in cellular and molecular biology to mammalian protein expression, and their glycosylation and purification. His research interests lie in the relationship between protein glycosylation and protein function, the impact of altered glycosylation on the initiation and progression of cancer, and studies of protein maturation and interactions regulated by glycosylation. He has published more than 40 papers that have acquired over 1800 citations to date.
Dr. Vitor H. Pomin is an Assistant Professor of Pharmacognosy and Assistant Research Professor at the Research Institute of Pharmaceutical Sciences of the University of Mississippi. He pursued his undergraduate course at the Institute of Biological Sciences, Federal University of Rio de Janeiro (UFRJ), Brazil, and graduate studies in Biological Chemistry at the Institute of Medical Biochemistry Leopoldo de Meis (IBqM), UFRJ. He received his Diploma of Licentiate, M.S., and Ph.D. in 2003, 2005, and 2008, respectively, all from UFRJ. After completing his Ph.D., he pursued a post-doctorate at the Complex Carbohydrate Research Center, University of Georgia, until 2011. After this time and prior to joining the University of Mississippi, he was an Assistant professor of Biological Chemistry, Biochemistry, Glycobiology, and NMR Spectroscopy (IBqM/UFRJ). He has over 110 published articles in peer-reviewed journals and has served as the main editor for six academic/scientific books. He currently serves as an editorial member and frequent ad hoc reviewer of many internationally recognized journals, like the Journal of Biological Chemistry, Chemical Reviews, Carbohydrate Polymers, Carbohydrate Research, Marine Drugs, Analytical Chemistry, Glycobiology, Journal of Natural Products, PLoS ONE, European Journal of Medicinal Chemistry, and many others. He conducts research on glycobiology (mostly sulfated polysaccharides), structural (glyco)biology, and NMR spectroscopy.
Dr. Mark Jon Olsen is a tenured Associate Professor at the Department of Pharmaceutical Sciences, College of Pharmacy, Midwestern University. Dr. Olsen graduated from the University of Wisconsin–Madison with a BS in Pharmaceutical Science in 1994 and attended graduate school at the University of Texas at Austin in the Department of Chemistry, where he worked under Dr. Brent Iverson and Dr. George Georgiou on the synthesis of fluorescent probes for high-throughput enzyme engineering in the Department of Chemistry and obtained his Ph.D. in Chemistry in 2003. His research interests include ASPH, antiepileptogenic agents, inhibition of 2-oxoglutarate utilizing enzymes, and aspartyl-beta-hydroxylase inhibitors for anticancer treatment. Dr. Olsen is an active member of the American Chemical Society and American Association of Colleges of Pharmacy.
Radoslav Goldman is a Professor of Oncology and Biochemistry and Molecular and Cellular Biology at Georgetown University and the Director of the Clinical and Translational Glycoscience Research Center of the university. He graduated from the University of California with a B.S. in 1990. Subsequently, he studied enzymology with Michael Marletta and organic chemistry with Masato Koreeda at the University of Michigan as well as redox chemistry and toxicology with Valerian Kagan at the University of Pittsburgh, and he completed his postdoctoral training in the laboratory of Curtis Harris at the National Cancer Institute before starting his research at Georgetown University. Dr. Goldman's laboratory has been continuously supported for 20 years by the National Institutes of Health and other agencies to conduct translational cancer research. His research lies in the translational studies of head and neck squamous cell carcinoma (HNSCC), the structure function of heparan 6-O-endosulfatases, and the progression of liver fibrosis to hepatocellular carcinoma (HCC).
